Gershoni A - Search Results

1

Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients.

Hassin O, Nataraj NB, Shreberk-Shaked M, Aylon Y, Yaeger R, Fontemaggi G, Mukherjee S, Maddalena M, Avioz A, Iancu O, Mallel G, Gershoni A, Grosheva I, Feldmesser E, Ben-Dor S, Golani O, Hendel A, Blandino G, Kelsen D, Yarden Y, Oren M. Hassin O, et al. Among authors: gershoni a. Nat Commun. 2022 May 19;13(1):2800. doi: 10.1038/s41467-022-30481-7. Nat Commun. 2022. PMID: 35589715 Free PMC article.

2

The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.

Aylon Y, Gershoni A, Rotkopf R, Biton IE, Porat Z, Koh AP, Sun X, Lee Y, Fiel MI, Hoshida Y, Friedman SL, Johnson RL, Oren M. Aylon Y, et al. Among authors: gershoni a. Genes Dev. 2016 Apr 1;30(7):786-97. doi: 10.1101/gad.274167.115. Epub 2016 Mar 24. Genes Dev. 2016. PMID: 27013235 Free PMC article.

3

A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.

Kotler E, Shani O, Goldfeld G, Lotan-Pompan M, Tarcic O, Gershoni A, Hopf TA, Marks DS, Oren M, Segal E. Kotler E, et al. Among authors: gershoni a. Mol Cell. 2018 Jul 5;71(1):178-190.e8. doi: 10.1016/j.molcel.2018.06.012. Mol Cell. 2018. PMID: 29979965 Free article.

4

LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state.

Furth N, Pateras IS, Rotkopf R, Vlachou V, Rivkin I, Schmitt I, Bakaev D, Gershoni A, Ainbinder E, Leshkowitz D, Johnson RL, Gorgoulis VG, Oren M, Aylon Y. Furth N, et al. Among authors: gershoni a. Life Sci Alliance. 2018 Oct 30;1(5):e201800171. doi: 10.26508/lsa.201800171. eCollection 2018 Oct. Life Sci Alliance. 2018. PMID: 30456386 Free PMC article.

5

Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.

Mukherjee S, Maddalena M, Lü Y, Martinez S, Nataraj NB, Noronha A, Sinha S, Teng K, Cohen-Kaplan V, Ziv T, Arandkar S, Hassin O, Chatterjee R, Pirona AC, Shreberk-Shaked M, Gershoni A, Aylon Y, Elazar Z, Yarden Y, Schramek D, Oren M. Mukherjee S, et al. Among authors: gershoni a. Proc Natl Acad Sci U S A. 2022 Apr 26;119(17):e2119644119. doi: 10.1073/pnas.2119644119. Epub 2022 Apr 19. Proc Natl Acad Sci U S A. 2022. PMID: 35439056 Free PMC article.

6

TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.

Gershoni A, Hassin O, Nataraj NB, Baruch S, Avioz-Seligman A, Pirona AC, Fellus-Alyagor L, Meir Salame T, Mukherjee S, Mallel G, Yarden Y, Aylon Y, Oren M. Gershoni A, et al. Mol Oncol. 2023 Dec;17(12):2675-2693. doi: 10.1002/1878-0261.13525. Epub 2023 Oct 16. Mol Oncol. 2023. PMID: 37716913 Free PMC article.

7

A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.

Kotler E, Shani O, Goldfeld G, Lotan-Pompan M, Tarcic O, Gershoni A, Hopf TA, Marks DS, Oren M, Segal E. Kotler E, et al. Among authors: gershoni a. Mol Cell. 2018 Sep 6;71(5):873. doi: 10.1016/j.molcel.2018.08.013. Mol Cell. 2018. PMID: 30193102 Free PMC article. No abstract available.

8

Minimally invasive micro sclerostomy (MIMS) procedure in the treatment of open-angle glaucoma.

Voskanyan L, Ahmed IIK, Gershoni A, Barayev E, Papoyan V, Ghazaryan A, Bar-Ilan O, Zahavi A, Glovinsky Y, Geffen N. Voskanyan L, et al. Among authors: gershoni a. BMC Ophthalmol. 2024 Mar 18;24(1):122. doi: 10.1186/s12886-024-03384-y. BMC Ophthalmol. 2024. PMID: 38494493 Free PMC article. Clinical Trial.

9

Corneal pseudoectasia: a case series.

Chorny A, Gershoni A, Mahler O, Sorkin N, Nahum Y, Sella R, Bahar I, Livny E. Chorny A, et al. Among authors: gershoni a. Int Ophthalmol. 2024 Feb 7;44(1):17. doi: 10.1007/s10792-024-02992-3. Int Ophthalmol. 2024. PMID: 38321320

10

Mechanical impact of epiretinal membranes on the retina utilizing finite element analysis.

Naftali S, Della Rocca K, Gershoni A, Ehrlich R, Ratnovsky A. Naftali S, et al. Among authors: gershoni a. Comput Methods Programs Biomed. 2024 Mar;245:108020. doi: 10.1016/j.cmpb.2024.108020. Epub 2024 Jan 12. Comput Methods Programs Biomed. 2024. PMID: 38237448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page